Velcade
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Orphan Nano drugs such as Rituxan, Revlimid, Soliris, Afinitor, Tasigna, Velcade, Avonex, Alimta, Yervoy, Sprycel, Rebif…
( This article may be cited as Manickam Palaniappan, Shenoy Maithili, Woldie Indryas , Hari Pawan, Tuliani Tushar, Byrnes Timothy…
In the past decade we have seen four new agents approved by the US Food and Drug Administration for treatment of multiple myeloma…
A more widespread adoption of an approach taken by a new scheme in which payment for an anticancer drug is linked to treatment…
We have further defined mechanism(s) by which OSU-03012 (OSU), a derivative of the COX2 inhibitor Celecoxib but lacking COX2…
Background: PS 341 has demonstrated activity in multiple myeloma (MM), and PXD 101 is a new HDAC inhibitor, currently being…
The first three clinical studies of bortezomib tested regimens of differing dose-intensities: once weekly for 4 wk on a 6 wk…
7107 Background: Tax, a microtubule stabilizer, is active against NSCLC. Bortezomib (VELCADE), a reversible proteasome inhibitor…
The proteasome is a multiprotease complex that degrades the majority of cellular proteins in a highly regulated manner. The…